Stage FocusSeries B+
GeographyUS
TypeGrowth Equity
Last Activity2026
Industry Focus
Industries
BiotechAI
Technical BenchLimited
Investor TypeGeneralist
ExposureMinimal DeepTech Investments
Bio
Irving Investors is a Denver-based crossover investment fund founded in 2009 by Jeremy Abelson after two earlier technology exits. It runs a predominantly long-only public equities strategy alongside an active late-stage venture portfolio, and has since expanded into credit and private investments; the firm also keeps an office in New York. It describes itself as sector agnostic, applying a single...
Similar Funds
BV
Brightstone Venture Capital
Minneapolis, Minnesota, United States
GeneralistBiotechAIMedtechSeedSeries A
Bristol-Myers Squibb (Strategic Investments)
New York, United States
GeneralistBiotechMedtechAISeries ASeries B+
Devonshire Investors
Boston, United States
GeneralistBiotechAIClimate TechSeries ASeries B+
HV
Hummingbird VC
London, United Kingdom
GeneralistBiotechAIBlockchainPre-SeedSeed
New Enterprise Associates (NEA)
Menlo Park, United States
GeneralistBiotechAIMedtechSeedSeries A
OP
OCV Partners
Los Angeles, California, United States
GeneralistBiotechMedtechCybersecuritySeries ASeries B+